Response Biomedical Corp. (RPBIF.OB) Receives FDA Market Clearance for Rapid Respiratory Syncytial Virus Test

QualityStocks would like to highlight Response Biomedical Corp. (OTCBB: RPBIF). The company develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP(R) Platform for clinical and environmental applications. RAMP(R) represents a new paradigm in diagnostics that provides high sensitivity and reliable information in minutes. It is ideally suited to both point-of-care testing and laboratory use products and services more effectively and efficiently.

In the company’s news yesterday,

Response Biomedical Corporation announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to market the company’s rapid Respiratory Syncytial Virus (RSV) test. The test runs on the RAMP(R) 200 Reader and will be marketed and sold by 3M Health Care as the 3M(TM) Rapid Detection RSV Test.

The RSV Test is a qualitative immunochromatographic assay designed to be used as an in vitro diagnostic product with the 3M(TM) Rapid Detection Reader (manufactured by Response Biomedical) to detect the presence of RSV F-protein antigens in nasopharyngeal swab, nasopharyngeal aspirate, or nasal wash/aspirate specimens. Detecting RSV facilitates the rapid diagnosis of RSV viral infections in symptomatic patients.

“FDA clearance of our rapid RSV test adds another product to the 3M arsenal that addresses the growing need for detecting upper respiratory infections,” stated S. Wayne Kay, CEO of Response Biomedical. “3M Health Care is expected to introduce this product in the upcoming RSV season, which closely mirrors the influenza season. 3M Health Care currently markets the 3M(TM) Rapid Detection Flu A+B Test in the U.S. and is exploring other market expansion opportunities. Having an additional test, which runs on the 3M(TM) Rapid Detection Reader, should heighten market interest in these innovative products and, once again, demonstrates the potential of Response Biomedical’s platform technology.”

About QualityStocks

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.

To sign up for “The QualityStocks Daily Newsletter” please visit http://www.qualitystocks.net/

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net 

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.